FluoroPharma Medical, Inc. (FPMI) Raises a Collective Total of $7M in 2011
FluoroPharma Medical, Inc., a company specializing in the development of breakthrough diagnostic imaging products that utilize positron emission tomography (PET) technology to detect and assess pathology before clinical manifestation of diseases, announced this morning that they have secured an additional $1.010 million, bringing the total to more than $7 million over the course of 2011 from institutional and accredited investors. "We are excited by the opportunities this additional working capital creates for FluoroPharma to significantly accelerate development of our pipeline," stated Thijs Spoor, FluoroPharma's President and CEO. "The funding will allow us to further advance our most promising portfolio of…